Boehringer Ingelheim's Humira biosimilar accepted for review in US and Europe
The EMA and US FDA have agreed to review a candidate Humira (adalimumab) biosimilar developed by Boehringer Ingelheim.
Archives for January 20, 2017
Biopharma survey: Shortage of bioprocessing talent key threat to sector
Industry is struggling to find and develop skilled bioprocessing workers according to respondents to NIBRT’s biopharma trends survey.
Cell preservation prosperity: BioLife and Cryoport up on personalised meds
With increased interest in cell and gene therapies, BioLife Solutons has reported a 28% year-on-year growth in sales of biopreservation media, while Cryoport has struck another logistics deal.